Access to patient-level data from GlaxoSmithKline clinical trials.

dc.contributor.author

Nisen, Perry

dc.contributor.author

Rockhold, Frank

dc.coverage.spatial

United States

dc.date.accessioned

2015-12-03T17:29:52Z

dc.date.issued

2013-08-01

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/23902490

dc.identifier.eissn

1533-4406

dc.identifier.uri

https://hdl.handle.net/10161/11001

dc.language

eng

dc.publisher

Massachusetts Medical Society

dc.relation.ispartof

N Engl J Med

dc.relation.isversionof

10.1056/NEJMsr1302541

dc.subject

Access to Information

dc.subject

Clinical Trials as Topic

dc.subject

Confidentiality

dc.subject

Drug Evaluation

dc.subject

Drug Industry

dc.subject

Humans

dc.subject

Information Dissemination

dc.subject

Internet

dc.title

Access to patient-level data from GlaxoSmithKline clinical trials.

dc.type

Journal article

duke.contributor.orcid

Rockhold, Frank|0000-0003-3732-4765

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/23902490

pubs.begin-page

475

pubs.end-page

478

pubs.issue

5

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

369

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nisen Rockhold NEJM SHARE.pdf
Size:
370.14 KB
Format:
Adobe Portable Document Format